NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a new initiative with Bristol Myers Squibb (NYSE: BMY). This collaboration ...
RBM20 truncating variants ( RBM20 tvs) appear to contribute to arrhythmogenic dilated cardiomyopathy (DCM) but with ...
The registrational intent ACR-368 Phase 2b study is advancing with a prespecified simultaneous interim analysis and data update for both ...
SkylineDx, an innovative company specializing in molecular diagnostics for dermatology, today announced data from two oral and one e-poster presentation, focusing on CSCC, at the 83rd Society for ...
Scientists who focus only on generating data risk missing their role in shaping strategy and driving innovation.
THE campaign to promote the adoption of electric vehicles (EVs) as an alternative to internal combustion engine (ICE) cars is ...
An at-home, mail-in, finger-stick blood test detected Alzheimer’s-related biomarkers associated with cognitive performance in ...
Patients with idiopathic intracranial hypertension lost weight and had fewer headaches with GLP-1 receptor agonists, ...
Researchers developed a model to predict risk of TIPN in patients with early-stage cancer treated with a taxane regimen.
Researchers demonstrated that self-administered fingerprick blood tests measuring p-tau217 and GFAP, returned by post, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results